Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study.
Orphanet J Rare Dis. 2019 Nov 15;14(1):260. doi: 10.1186/s13023-019-1240-0.
Orphanet J Rare Dis. 2019.
PMID: 31730475
Free PMC article.
BACKGROUND: Acquired thrombotic thrombocytopenic Purpura (aTTP) is a life-threatening ultra-orphan disease with a reported annual incidence between 1.5 and 6.0 cases per million in Europe and mainly affecting otherwise young and healthy adults aged 40 …
BACKGROUND: Acquired thrombotic thrombocytopenic Purpura (aTTP) is a life-threatening ultra-orphan disease with …
Effectiveness and safety of caplacizumab in acquired thrombotic thrombocytopenic purpura: health technology assessment and classification according to the methodology established in Colombia.
Soto-Mora JA, Gómez-Espitia LM, Lasalvia P, Castellanos Moreno CA, Casallas Vanegas CA, Londoño Gutiérrez SA.
Soto-Mora JA, et al.
Int J Technol Assess Health Care. 2023 Jul 21;39(1):e48. doi: 10.1017/S0266462323000442.
Int J Technol Assess Health Care. 2023.
PMID: 37476982
OBJECTIVES: Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare hematological disease whose clinical management includes caplacizumab along with plasma exchange and immunosuppression, according to international guidelines. ...
OBJECTIVES: Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare hematological disease whose clinical m …
Item in Clipboard
Comparison of the Long-Term Remission of Rituximab and Conventional Treatment for Acquired Thrombotic Thrombocytopenic Purpura: A Systematic Review and Meta-Analysis.
Owattanapanich W, Wongprasert C, Rotchanapanya W, Owattanapanich N, Ruchutrakool T.
Owattanapanich W, et al.
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029618825309. doi: 10.1177/1076029618825309.
Clin Appl Thromb Hemost. 2019.
PMID: 30808221
Free PMC article.
The current systematic review and meta-analysis aimed to summarize the results of all available studies to compare the efficacies of rituximab and conventional treatment for acquired thrombotic thrombocytopenic purpura (TTP). Three investigators indepe …
The current systematic review and meta-analysis aimed to summarize the results of all available studies to compare the efficacies of rituxim …
Item in Clipboard
Cite
Cite